Peanut Allergy
📧 Sign up to get email alerts when something new happens for Peanut Allergy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-05-29Clinical Trial Update: The Grown Up Peanut Immunotherapy Study [NA]
A peanut allergy immunotherapy trial sponsored by Guy's and St Thomas' NHS Foundation Trust has completed.
-
CLINICAL_TRIALS trial_result · 2024-03-29Clinical Trial Update: Follow up of LEAP Participants and Their Families
A completed clinical trial update related to peanut allergy (NCT03546413) with results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-03-29Clinical Trial Update: Boiled Peanut Oral Immunotherapy for the Treatment of Peanut Allergy: a Pilot Study [NA]
A pilot clinical trial investigating boiled peanut oral immunotherapy for IgE-mediated peanut allergy has completed with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2024-02-07Clinical Trial Update: Study in Pediatric Subjects With Peanut Allergy to Evaluate Efficacy and Safety of Dupilumab as Adjunct to AR101 (Peanut Oral Immunotherapy) [Phase 2]
Phase 2 pediatric trial evaluating dupilumab as an adjunct to peanut oral immunotherapy (AR101) for peanut allergy; study completed with res…
-
CLINICAL_TRIALS trial_result · 2024-01-19Clinical Trial Update: Peanut Oral Immunotherapy in Children With Peanut Allergy (Peanut Flour) [Phase 1]
Phase 1 trial update evaluating peanut oral immunotherapy using peanut flour in children with peanut allergy; results posted after completio…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-10-18Clinical Trial Update: VE416 for Treatment of Food Allergy [Phase 1, Phase 2]
Clinical trial update for VE416 investigating treatment of peanut allergy in Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2023-07-27Clinical Trial Update: Study to Investigate Etokimab (ANB020) Activity in Adult Participants With Peanut Allergy [Phase 2]
A Phase 2 study evaluating etokimab (ANB020) for adults with peanut allergy has completed, with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-03-02Clinical Trial Update: Peanut Oral Immunotherapy Study of Early Intervention for Desensitization [Phase 3]
Phase 3 trial update for peanut oral immunotherapy in early intervention for desensitization; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2023-01-30Clinical Trial Update: Salvage Peanut Oral Immunotherapy Study [Phase 1, Phase 2]
Clinical trial update for salvage peanut oral immunotherapy in peanut allergy completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2022-06-30Clinical Trial Update: Follow-up of the VIPES Study to Evaluate Efficacy and Safety of Viaskin Peanut in Adults and Children [Phase 2]
A Phase 2 clinical trial update for Viaskin Peanut in adults and children with peanut allergy, reporting completed status and posted results…
-
CLINICAL_TRIALS trial_result · 2022-05-19Clinical Trial Update: Study to Evaluate Dupilumab Monotherapy in Pediatric Patients With Peanut Allergy [Phase 2]
Phase 2 trial evaluating dupilumab monotherapy in pediatric patients with peanut allergy has completed and results posted.
-
CLINICAL_TRIALS trial_result · 2022-03-17Clinical Trial Update: Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitization in Children and Adults (PALISADE) [Phase 3]
Phase 3 trial update for AR101 (peanut oral immunotherapy) in desensitization for children and adults with peanut allergy.
-
CLINICAL_TRIALS trial_result · 2022-02-02Clinical Trial Update: Peanut Allergy Oral Immunotherapy Desensitization [Phase 2]
Phase 2 clinical trial update for peanut allergy oral immunotherapy desensitization completed.
-
CLINICAL_TRIALS trial_result · 2021-12-15Clinical Trial Update: PALISADE Follow-on Study (ARC004) [Phase 3]
Phase 3 follow-on study (ARC004) for peanut allergy completed; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-11-09Clinical Trial Update: Oral Desensitization to Peanut in Peanut Allergic Children and Adults Using CPNA Peanut OIT Safety Follow-On Study [Phase 2]
Phase 2 trial update on oral desensitization to peanut in peanut-allergic children and adults using CPNA peanut OIT safety follow-on study; …
-
CLINICAL_TRIALS trial_result · 2021-11-02Clinical Trial Update: Real-World AR101 Market-Supporting Experience Study in Peanut-Allergic Children (RAMSES) [Phase 3]
Phase 3 RAMSES real-world study in peanut-allergic children completed; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-11-02Clinical Trial Update: Oral Desensitization to Peanut in Peanut-Allergic Children and Adults Using Characterized Peanut Allergen OIT [Phase 2]
Phase 2 clinical trial evaluating oral desensitization to peanut in peanut-allergic individuals using characterized peanut allergen (OIT) ha…
-
CLINICAL_TRIALS trial_result · 2021-11-02Clinical Trial Update: AR101 Real-World Open-Label Extension Study [Phase 3]
Open-label extension of AR101 in peanut allergy completed; results posted in 2021. It provides long-term safety and tolerability data from a…
-
CLINICAL_TRIALS trial_result · 2021-10-29Clinical Trial Update: Peanut Oral Immunotherapy in Children: IMPACT Follow Up Study [Phase 2]
A Phase 2 follow-up study evaluating peanut oral immunotherapy in children has completed; results were posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-10-27Clinical Trial Update: Efficacy and Safety of Several Doses of Viaskin Peanut in Adults and Children With Peanut Allergy [Phase 2]
Phase 2 trial update on efficacy and safety of multiple Viaskin Peanut doses in adults and children with peanut allergy; results posted afte…
-
CLINICAL_TRIALS trial_result · 2021-10-15Clinical Trial Update: Efficacy and Safety of Viaskin Peanut in Children With Immunoglobulin E (IgE)-Mediated Peanut Allergy [Phase 3]
Phase 3 trial results for Viaskin Peanut in children with IgE-mediated peanut allergy have been completed and results posted. The update sum…
-
CLINICAL_TRIALS trial_result · 2021-08-03Clinical Trial Update: ARTEMIS Peanut Allergy In Children [Phase 3]
Phase 3 trial update for ARTEMIS evaluating peanut allergy in children; study completed with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-07-28Clinical Trial Update: Tolerance Following Peanut Oral Immunotherapy [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating tolerance after peanut oral immunotherapy completed with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-07-13Clinical Trial Update: Real World, Open Label, QOL Assessment of Peanut Immunotherapy AR101 in Children and Adolescents [Phase 3]
Phase 3 real-world, open-label study of AR101 for peanut allergy in children and adolescents; terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2021-02-03Clinical Trial Update: Safety Study of Viaskin Peanut to Treat Peanut Allergy [Phase 3]
Phase 3 safety study of Viaskin Peanut for peanut allergy has completed.